Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis
Prostate Cancer · 2011
DOI: 10.1155/2011/249290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prostate Cancer, 2011. Verfasst von Raymond B Nagle und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, USA. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
This paper proposes that human prostate carcinoma primarily invades as a cohesive cell collective through a mechanism similar to embryonic tubulogenesis, instead of the popular epithelial-mesenchymal transformation (EMT) model. Evidence supporting a tubulogenesis model is presented, along with suggestions for additional research. Additionally, observations documenting cell adhesion molecule changes in tissue and stromal components are reviewed, allowing for comparisons between the current branching morphogenesis models and the tubulogenesis model. Finally, the implications of this model on prevailing views of therapeutic and diagnostic strategies for aggressive prostatic disease are considered.
Autor:innen und Institutionen
- Department of Pathology, The Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, USA.
Förderung
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Nagle, R. B., & Cress, A. E. (2011). Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis. Prostate Cancer. https://doi.org/10.1155/2011/249290
Vancouver
Nagle RB, Cress AE. Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis. Prostate Cancer. 2011. doi:10.1155/2011/249290
BibTeX
@article{Nagle2011,
author = {Nagle, Raymond B and Cress, Anne E},
title = {Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis},
journal = {Prostate Cancer},
year = {2011},
doi = {10.1155/2011/249290}
}
EUVIMED